• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

群体药代动力学的非参数最大似然估计及其在环孢素中的应用。

Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine.

作者信息

Mallet A, Mentré F, Steimer J L, Lokiec F

机构信息

INSERM U194, Service d'Informatique Médicale, Paris, France.

出版信息

J Pharmacokinet Biopharm. 1988 Jun;16(3):311-27. doi: 10.1007/BF01062140.

DOI:10.1007/BF01062140
PMID:3065480
Abstract

A new method, nonparametric maximum likelihood (NPML), for statistical analysis of population kinetic data is proposed. NPML provides a discrete estimate of the whole probability density function of the pharmacokinetic parameters. This permits a straightforward derivation of usual population characteristics. To illustrate the application of the NPML method, a population analysis of cyclosporine RIA measured plasma levels in 188 bone marrow transplant patients after intravenous infusion, is presented. The capability of NPML to extract population information from sparse individual data is also outlined.

摘要

提出了一种用于群体动力学数据统计分析的新方法——非参数最大似然法(NPML)。NPML提供了药代动力学参数整个概率密度函数的离散估计。这使得能够直接推导常见的群体特征。为了说明NPML方法的应用,本文给出了对188例骨髓移植患者静脉输注后环孢素放射免疫分析测定的血浆水平进行的群体分析。还概述了NPML从稀疏个体数据中提取群体信息的能力。

相似文献

1
Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine.群体药代动力学的非参数最大似然估计及其在环孢素中的应用。
J Pharmacokinet Biopharm. 1988 Jun;16(3):311-27. doi: 10.1007/BF01062140.
2
An application of population pharmacokinetics to the clinical use of cyclosporine in bone marrow transplant patients.群体药代动力学在骨髓移植患者环孢素临床应用中的应用。
Transplant Proc. 1988 Apr;20(2 Suppl 2):466-70.
3
Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation.多西他赛在I期研究期间的群体药代动力学,采用非线性混合效应模型和非参数最大似然估计法。
Cancer Chemother Pharmacol. 1995;37(1-2):47-54. doi: 10.1007/BF00685628.
4
Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients.骨髓移植受者两种静脉输注环孢素方案的比较。
Transplantation. 1988 Apr;45(4):810-3.
5
Single-dose cyclosporine pharmacokinetics in various biological fluids of patients receiving allogeneic marrow transplantation.
Ther Drug Monit. 1990 Mar;12(2):134-8. doi: 10.1097/00007691-199003000-00004.
6
Cyclosporine pharmacokinetics in the early course of renal transplantation.肾移植早期环孢素的药代动力学
Transplant Proc. 1987 Feb;19(1 Pt 2):1719.
7
Bayesian estimation of cyclosporine clearance in bone marrow graft.骨髓移植中环孢素清除率的贝叶斯估计。
Ther Drug Monit. 1990 Jan;12(1):16-22. doi: 10.1097/00007691-199001000-00004.
8
Influence of infusion duration on the efficacy and toxicity of intravenous cyclosporine in bone marrow transplant patients.输注持续时间对骨髓移植患者静脉注射环孢素疗效和毒性的影响。
Transplant Proc. 1988 Jun;20(3 Suppl 3):501-4.
9
Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.肾移植受者中环孢素与高剂量类固醇的相互作用:通过高效液相色谱法进行评估。
Transplant Proc. 1987 Feb;19(1 Pt 2):1728-9.
10
Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.环孢素在异基因骨髓移植后预防移植物抗宿主病中的应用。
Transplant Proc. 1988 Jun;20(3 Suppl 3):461-9.

引用本文的文献

1
Population pharmacokinetics of cyclosporine in transplant recipients.移植受者环孢素的群体药代动力学。
AAPS J. 2013 Oct;15(4):901-12. doi: 10.1208/s12248-013-9500-8. Epub 2013 Jun 18.
2
A Bayesian hierarchical nonlinear mixture model in the presence of artifactual outliers in a population pharmacokinetic study.在群体药代动力学研究中存在人为异常值时的贝叶斯分层非线性混合模型。
J Pharmacokinet Pharmacodyn. 2011 Oct;38(5):613-36. doi: 10.1007/s10928-011-9211-7. Epub 2011 Aug 17.
3
Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects models.

本文引用的文献

1
Predicting individual phenytoin dosage.
J Pharmacokinet Biopharm. 1981 Apr;9(2):131-46. doi: 10.1007/BF01068078.
2
Random-effects models for longitudinal data.纵向数据的随机效应模型。
Biometrics. 1982 Dec;38(4):963-74.
3
Cyclosporin A: correlation between HPLC and RIA serum levels.环孢素A:高效液相色谱法与放射免疫分析法测定血清水平的相关性
Pharm Weekbl Sci. 1982 Jun 25;4(3):84-6. doi: 10.1007/BF01962250.
两种自举法在非线性混合效应模型中获取非参数参数分布不精确估计的应用。
J Pharmacokinet Pharmacodyn. 2011 Feb;38(1):63-82. doi: 10.1007/s10928-010-9177-x. Epub 2010 Nov 13.
4
Evaluation of an extended grid method for estimation using nonparametric distributions.使用非参数分布的扩展网格估计方法评估
AAPS J. 2009 Sep;11(3):615-27. doi: 10.1208/s12248-009-9138-8.
5
Evaluation of the nonparametric estimation method in NONMEM VI: application to real data.NONMEM VI中非线性估计方法的评估:在实际数据中的应用
J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):297-315. doi: 10.1007/s10928-009-9122-z. Epub 2009 Jul 2.
6
Pharmacokinetic-pharmacodynamic modeling of the miotic effects of dihydrocodeine in humans.二氢可待因对人体缩瞳作用的药代动力学-药效学建模
Eur J Clin Pharmacol. 2007 Nov;63(11):1045-54. doi: 10.1007/s00228-007-0363-8. Epub 2007 Sep 5.
7
Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children.新生儿、婴儿和儿童中阿米卡星的非参数群体药代动力学分析。
Antimicrob Agents Chemother. 2002 May;46(5):1381-7. doi: 10.1128/AAC.46.5.1381-1387.2002.
8
A use of Monte Carlo integration for population pharmacokinetics with multivariate population distribution.
J Pharmacokinet Biopharm. 1998 Feb;26(1):103-23. doi: 10.1023/a:1023280909207.
9
Bayesian nonparametric population models: formulation and comparison with likelihood approaches.贝叶斯非参数总体模型:公式化及与似然方法的比较
J Pharmacokinet Biopharm. 1997 Apr;25(2):235-53. doi: 10.1023/a:1025736230707.
10
Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models.
J Pharmacokinet Biopharm. 1997 Apr;25(2):209-33. doi: 10.1023/a:1025784113869.
4
OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics.OPT:一套用于临床药代动力学参数优化的计算机程序。
Br J Clin Pharmacol. 1982 Aug;14(2):247-56. doi: 10.1111/j.1365-2125.1982.tb01969.x.
5
Empirical Bayes estimation of individual growth-curve parameters and their relationship to covariates.个体生长曲线参数的经验贝叶斯估计及其与协变量的关系。
Biometrics. 1983 Mar;39(1):71-86.
6
Estimating population kinetics.估计群体动力学。
Crit Rev Biomed Eng. 1982;8(3):195-222.
7
Population pharmacokinetic data and parameter estimation based on their first two statistical moments.基于前两个统计矩的群体药代动力学数据和参数估计。
Drug Metab Rev. 1984;15(1-2):173-93. doi: 10.3109/03602538409015064.
8
Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.群体药代动力学参数估计方法的评价。III. 单指数模型:常规临床药代动力学数据
J Pharmacokinet Biopharm. 1983 Jun;11(3):303-19. doi: 10.1007/BF01061870.
9
Pharmacokinetics of intravenous cyclosporine in bone marrow transplant patients. Comparison of two assay methods.
Transplantation. 1984 Nov;38(5):511-3. doi: 10.1097/00007890-198411000-00014.
10
Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay.
Clin Chem. 1983 Jan;29(1):180-3.